PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
MLTX vs. MMYT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between MLTX and MMYT is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

MLTX vs. MMYT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in MoonLake Immunotherapeutics (MLTX) and MakeMyTrip Limited (MMYT). The values are adjusted to include any dividend payments, if applicable.

0.00%10.00%20.00%30.00%40.00%50.00%JulyAugustSeptemberOctoberNovemberDecember
35.75%
37.80%
MLTX
MMYT

Key characteristics

Sharpe Ratio

MLTX:

-0.19

MMYT:

2.90

Sortino Ratio

MLTX:

0.08

MMYT:

3.13

Omega Ratio

MLTX:

1.01

MMYT:

1.42

Calmar Ratio

MLTX:

-0.23

MMYT:

7.01

Martin Ratio

MLTX:

-0.37

MMYT:

20.48

Ulcer Index

MLTX:

25.35%

MMYT:

7.25%

Daily Std Dev

MLTX:

50.16%

MMYT:

51.14%

Max Drawdown

MLTX:

-64.60%

MMYT:

-73.45%

Current Drawdown

MLTX:

-18.31%

MMYT:

-7.85%

Fundamentals

Market Cap

MLTX:

$3.34B

MMYT:

$12.96B

EPS

MLTX:

-$1.27

MMYT:

$1.90

Total Revenue (TTM)

MLTX:

$39.48K

MMYT:

$882.62M

Gross Profit (TTM)

MLTX:

-$34.48K

MMYT:

$491.36M

EBITDA (TTM)

MLTX:

-$108.45M

MMYT:

$158.93M

Returns By Period

In the year-to-date period, MLTX achieves a -13.61% return, which is significantly lower than MMYT's 136.27% return.


MLTX

YTD

-13.61%

1M

4.72%

6M

35.75%

1Y

-10.99%

5Y*

N/A

10Y*

N/A

MMYT

YTD

136.27%

1M

3.48%

6M

37.80%

1Y

145.20%

5Y*

36.11%

10Y*

15.09%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

MLTX vs. MMYT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for MoonLake Immunotherapeutics (MLTX) and MakeMyTrip Limited (MMYT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for MLTX, currently valued at -0.19, compared to the broader market-4.00-2.000.002.00-0.192.90
The chart of Sortino ratio for MLTX, currently valued at 0.08, compared to the broader market-4.00-2.000.002.004.000.083.13
The chart of Omega ratio for MLTX, currently valued at 1.01, compared to the broader market0.501.001.502.001.011.42
The chart of Calmar ratio for MLTX, currently valued at -0.23, compared to the broader market0.002.004.006.00-0.237.01
The chart of Martin ratio for MLTX, currently valued at -0.37, compared to the broader market-5.000.005.0010.0015.0020.0025.00-0.3720.48
MLTX
MMYT

The current MLTX Sharpe Ratio is -0.19, which is lower than the MMYT Sharpe Ratio of 2.90. The chart below compares the historical Sharpe Ratios of MLTX and MMYT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.005.006.00JulyAugustSeptemberOctoberNovemberDecember
-0.19
2.90
MLTX
MMYT

Dividends

MLTX vs. MMYT - Dividend Comparison

Neither MLTX nor MMYT has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

MLTX vs. MMYT - Drawdown Comparison

The maximum MLTX drawdown since its inception was -64.60%, smaller than the maximum MMYT drawdown of -73.45%. Use the drawdown chart below to compare losses from any high point for MLTX and MMYT. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-18.31%
-7.85%
MLTX
MMYT

Volatility

MLTX vs. MMYT - Volatility Comparison

MoonLake Immunotherapeutics (MLTX) has a higher volatility of 16.74% compared to MakeMyTrip Limited (MMYT) at 10.45%. This indicates that MLTX's price experiences larger fluctuations and is considered to be riskier than MMYT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%12.00%14.00%16.00%18.00%20.00%22.00%JulyAugustSeptemberOctoberNovemberDecember
16.74%
10.45%
MLTX
MMYT

Financials

MLTX vs. MMYT - Financials Comparison

This section allows you to compare key financial metrics between MoonLake Immunotherapeutics and MakeMyTrip Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab